Johan Burisch on the costs of inflammatory bowel disease in high-income settings

The Lancet Gastroenterology & Hepatology in conversation with

Johan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology & Hepatology Commission on the cost of inflammatory bowel disease in high-income settings.
Read the Commission here:
The cost of inflammatory bowel disease in high-income settings

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv